NR4A1 and neoplasm: ER- and HER2+ tumors are generally more aggressive, and when comparing patients with a poor or good prognosis based on clinical parameters (lymphatic spread, tumor size and hormone receptor status) lower taurine levels in tissue from the poor-prognosis patients were detected [39].